Janet Howard Darbyshire | |
---|---|
Nationality | British |
Alma mater | London School of Hygiene and Tropical Medicine, MSc |
Occupation(s) | Epidemiologist and science administrator |
Employer | Medical Research Council (Clinical Trials Unit) |
Awards | Fellow of the Academy of Medical Sciences, the Royal College of Physicians, and the Society for Clinical Trials |
Janet Howard Darbyshire is a British epidemiologist and science administrator.
Darbyshire joined the Medical Research Council (MRC) in 1974, first co-ordinating clinical trials and epidemiological studies of tuberculosis, asthma and other respiratory diseases in the UK and East Africa for the MRC Tuberculosis and Chest Diseases Unit. She became the head of the MRC HIV Clinical Trials Centre when it was founded in 1989, designing and co-ordinating multi-centre trials of therapeutics for people with HIV, as well as vaccines and microbicides to prevent infection.
In 1980, Darbyshire was awarded an MSc by the London School of Hygiene and Tropical Medicine. [1]
In 1998, she became head of the new MRC Clinical Trials Unit, established as a centre of excellence for clinical trials, meta-analyses and epidemiological studies in HIV, cancer and other diseases. [2] She is also co-director of the UK Clinical Research Network (UKCRN). [3] As of 2013, she is on the board of the Lister Institute of Preventive Medicine and the Society for Clinical Trials. [4] [5]
Darbyshire is a fellow of the Academy of Medical Sciences, [6] the Royal College of Physicians [ citation needed ] and the Society for Clinical Trials. [7]
Already an Officer of the Order of the British Empire (OBE), she was elevated to Commander of the Order of the British Empire (CBE) in the 2010 New Year Honours for "services to Clinical Science". [8]
In 2018, Darbyshire was awarded the MRC Millennium Medal for her "world-leading research on clinical trials and epidemiology has prevented disease and saved lives across the world". [9]
The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).
Sir Rory Edwards Collins FMedSci FRS is a British physician who is Professor of Medicine and Epidemiology at the Clinical Trial Service Unit within the University of Oxford, the head of the Nuffield Department of Population Health and a Fellow of Green Templeton College, Oxford. His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer, while also being closely involved in developing approaches to the combination of results from related studies ("meta-analyses"). Since September 2005, he has been the Principal Investigator and Chief Executive of the UK Biobank, a prospective study of 500,000 British people aged 40–69 at recruitment.
Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.
Y Touring Theatre Company was a national touring theatre company which produced original plays and debates exploring contemporary issues. It was founded in 1989 by Nigel Townsend. The company was based in Kings Cross, London, England and was a former operation of Central YMCA.
Wafaa El-Sadr is a Columbia University Professor and the director of ICAP at Columbia University, Columbia World Projects and the Center for Infectious Disease Epidemiologic Research (CIDER) at Columbia Mailman School of Public Health.
Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.
Sheila Macdonald Bird OBE FRSE FMedSci is a Scottish biostatistician whose assessment of misuse of statistics in the British Medical Journal (BMJ) and BMJ series ‘Statistics in Question’ led to statistical guidelines for contributors to medical journals. Bird's doctoral work on non-proportional hazards in breast cancer found application in organ transplantation where beneficial matching was the basis for UK's allocation of cadaveric kidneys for a decade. Bird led the Medical Research Council (MRC) Biostatistical Initiative in support of AIDS/HIV studies in Scotland, as part of which Dr A. Graham Bird and she pioneered Willing Anonymous HIV Surveillance (WASH) studies in prisons. Her work with Cooper on UK dietary bovine spongiform encephalopathy (BSE) exposure revealed that the 1940–69 birth cohort was the most exposed and implied age-dependency in susceptibility to clinical vCJD progression from dietary BSE exposure since most vCJD cases were younger, born in 1970–89. Bird also designed the European Union's robust surveillance for transmissible spongiform encephalopathies in sheep which revolutionised the understanding of scrapie.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
Dame Anne Mandall Johnson DBE FMedSci is a British epidemiologist, known for her work in public health, especially the areas of HIV, sexually transmitted infections and infectious diseases.
Lalita Ramakrishnan is an Indian-born American microbiologist who is known for her contributions to the understanding of the biological mechanism of tuberculosis. As of 2019 she serves as a professor of Immunology and Infectious Diseases at the University of Cambridge, where she is also a Wellcome Trust Principal Research Fellow and a practicing physician. Her research is conducted at the MRC Laboratory of Molecular Biology, where she serves as the Head of the Molecular Immunity Unit of the Department of Medicine embedded at the MRC LMB. Working with Stanley Falkow at Stanford, she developed the strategy of using Mycobacterium marinum infection as a model for tuberculosis. Her work has appeared in a number of journals, including Science, Nature, and Cell. In 2018 and 2019 Ramakrishnan coauthored two influential papers in the British Medical Journal (BMJ) arguing that the widely accepted estimates of the prevalence of latent tuberculosis—estimates used as a basis for allocation of research funds—are far too high. She is married to Mark Troll, a physical chemist.
Christl Ann Donnelly is a professor of statistical epidemiology at Imperial College London, the University of Oxford and a Fellow of St Peter's College, Oxford. She serves as associate director of the MRC Centre for Global Infectious Disease Analysis. In 2022, Donnelly was appointed Head of the Department of Statistics, University of Oxford.
Donald S. Burke is an expert on the prevention, diagnosis, and control of infectious diseases of global concern. He is a distinguished University Professor of Health Science and Policy at the University of Pittsburgh.
Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.
Azra Catherine Hilary Ghani is a British epidemiologist who is a professor of Infectious Disease Epidemiology at Imperial College London. Her research considers the mathematical modelling of infectious diseases, including malaria, bovine spongiform encephalopathy and coronavirus. She has worked with the World Health Organization on their technical strategy for malaria. She is associate director of the MRC Centre for Global Infectious Disease Analysis.
Colin Baigent is a British academic physician and cardiovascular epidemiologist. He is a professor of epidemiology, Director of the Medical Research Council Population Health Research Unit at the University of Oxford, and deputy director of the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), part of Oxford Population Health. His work is focused in the design and coordination of large-scale randomised trials and the use of meta-analysis to assess the efficacy and safety of drugs for the prevention of cardiovascular disease (CVD) or premature death.
Gita Ramjee was a Ugandan-South African scientist and researcher in HIV prevention. In 2018, she was awarded the ‘Outstanding Female Scientist’ award from the European and Developing Countries Clinical Trials Partnership. She died in uMhlanga, South Africa, from COVID-19 related complications.
Guy Edward Thwaites is a British professor of infectious diseases at the University of Oxford, and director of the Oxford University Clinical Research Unit (OUCRU) in Ho Chi Minh City in Vietnam. His focus is on severe bacterial infections, including meningitis and Staphylococcus aureus bloodstream infection, and tuberculosis. He is a former first-class cricketer.